Follicular cell-derived thyroid cancer
- PMID: 27188261
- DOI: 10.1038/nrdp.2015.77
Follicular cell-derived thyroid cancer
Abstract
Follicular cell-derived thyroid cancers are derived from the follicular cells in the thyroid gland, which secrete the iodine-containing thyroid hormones. Follicular cell-derived thyroid cancers can be classified into papillary thyroid cancer (80-85%), follicular thyroid cancer (10-15%), poorly differentiated thyroid cancer (<2%) and undifferentiated (anaplastic) thyroid cancer (<2%), and these have an excellent prognosis with the exception of undifferentiated thyroid cancer. The advent and expansion of advanced diagnostic techniques has driven and continues to drive the epidemic of occult papillary thyroid cancer, owing to overdiagnosis of clinically irrelevant nodules. This transformation of the thyroid cancer landscape at molecular and clinical levels calls for the modification of management strategies towards personalized medicine based on individual risk assessment to deliver the most effective but least aggressive treatment. In thyroid cancer surgery, for instance, injuries to structures outside the thyroid gland, such as the recurrent laryngeal nerve in 2-5% of surgeries or the parathyroid glands in 5-10% of surgeries, negatively affect quality of life more than loss of the expendable thyroid gland. Furthermore, the risks associated with radioiodine ablation may outweigh the risks of persistent or recurrent disease and disease-specific mortality. Improvement in the health-related quality of life of survivors of follicular cell-derived thyroid cancer, which is decreased despite the generally favourable outcome, hinges on early tumour detection and minimization of treatment-related sequelae. Future opportunities include more widespread adoption of molecular and clinical risk stratification and identification of actionable targets for individualized therapies.
Similar articles
-
Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.Thyroid. 2016 Nov;26(11):1588-1597. doi: 10.1089/thy.2016.0247. Epub 2016 Sep 7. Thyroid. 2016. PMID: 27480016 Free PMC article.
-
Selective treatment of differentiated thyroid carcinoma.World J Surg. 1997 Jun;21(5):546-51; discussion 551-2. doi: 10.1007/pl00012284. World J Surg. 1997. PMID: 9204746
-
Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.Ann Intern Med. 1998 Oct 15;129(8):622-7. doi: 10.7326/0003-4819-129-8-199810150-00007. Ann Intern Med. 1998. PMID: 9786809
-
[Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].Duodecim. 2014;130(6):573-9. Duodecim. 2014. PMID: 24724456 Review. Finnish.
-
Prognosis and management of invasive well-differentiated thyroid cancer.Otolaryngol Clin North Am. 2010 Apr;43(2):301-28, viii. doi: 10.1016/j.otc.2010.02.002. Otolaryngol Clin North Am. 2010. PMID: 20510716 Review.
Cited by
-
Thyroid Carcinoma: A Review for 25 Years of Environmental Risk Factors Studies.Cancers (Basel). 2022 Dec 14;14(24):6172. doi: 10.3390/cancers14246172. Cancers (Basel). 2022. PMID: 36551665 Free PMC article. Review.
-
Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?Cancers (Basel). 2022 Feb 8;14(3):844. doi: 10.3390/cancers14030844. Cancers (Basel). 2022. PMID: 35159110 Free PMC article. Review.
-
TNFα-mediated activation of NF-κB downregulates sodium-iodide symporter expression in thyroid cells.PLoS One. 2020 Feb 12;15(2):e0228794. doi: 10.1371/journal.pone.0228794. eCollection 2020. PLoS One. 2020. PMID: 32049985 Free PMC article.
-
Resveratrol Inhibits the Tumorigenesis of Follicular Thyroid Cancer via ST6GAL2-Regulated Activation of the Hippo Signaling Pathway.Mol Ther Oncolytics. 2020 Jan 10;16:124-133. doi: 10.1016/j.omto.2019.12.010. eCollection 2020 Mar 27. Mol Ther Oncolytics. 2020. PMID: 32055676 Free PMC article.
-
Could Oxidative Stress Play a Role in the Development and Clinical Management of Differentiated Thyroid Cancer?Cancers (Basel). 2023 Jun 14;15(12):3182. doi: 10.3390/cancers15123182. Cancers (Basel). 2023. PMID: 37370792 Free PMC article. Review.
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical